fda:5
declines:2
approval:2
nabrivas:3
antibiotic:4
urinary:4
tract:4
infections:4
reuters:3
discover:1
thomson:3
reutersfinancialgovernment:1
solutionslegalreuters:1
news:1
agencyrisk:1
management:1
solutionstax:1
accountingblog:1
answers:1
oninnovation:1
reutersdirectory:1
siteslogincontactsupportbusinessmarketsworldpoliticstvmoreunited:1
states:3
health:1
newsjune:1
20:1
2020:2
852:1
2:1
days:1
agofda:1
infections2:1
min:1
readreuters:1
us:1
food:1
drug:4
administration:1
declined:2
approve:2
nabriva:4
therapeutics:1
plcs:1
complicated:2
citing:1
stillunresolved:1
manufacturing:4
issues:2
biopharmaceutical:1
company:3
said:5
friday:1
statement:2
complete:2
response:1
letter:1
resubmission:1
new:3
application:2
contepo:3
injection:1
cited:1
observations:2
companys:1
partners:2
could:1
resolved:2
due:1
fdas:2
inability:1
conduct:1
onsite:1
inspections:2
travel:1
restrictions:1
coronavirus:1
outbreak:1
request:2
clinical:1
data:1
raise:1
concerns:1
regard:1
safety:1
efficacy:1
april:1
last:1
year:1
asking:1
address:1
relating:1
deficiencies:1
one:1
contract:2
manufacturers:1
general:1
previously:1
identified:1
product:1
quality:1
facility:2
inspection:1
related:1
required:1
satisfactorily:1
nda:1
may:1
approved:1
chemically:1
known:1
fosfomycin:2
first:2
intravenously:1
administered:1
class:1
antibiotics:1
called:1
epoxide:1
united:2
discovered:1
1969:1
used:1
treat:1
variety:1
serious:1
bacterial:1
including:1
countries:1
outside:1
plans:2
meeting:1
discuss:1
next:1
steps:1
completing:1
foreign:1
reporting:1
kanishka:1
singh:1
bengaluru:1
editing:1
leslie:1
adlerour:1
standardsthe:1
trust:1
principlestrending1366:1
576narrowbrowserandphonemediumbrowserandportraittabletlandscapetabletmediumwidebrowserwidebrowserandlargermediumbrowserandlandscapetabletmediumwidebrowserandlargerabovephoneportraittabletandaboveaboveportraittabletlandscapetabletandabovelandscapetabletandmediumwidebrowserportraittabletandbelowlandscapetabletandbelowappsnewslettersadvertise:1
usadvertising:1
guidelinescookiesterms:1
useprivacyall:1
quotes:1
delayed:1
minimum:1
15:1
minutes:1
see:1
list:1
exchanges:1
delays:1
rights:1
reserved:1
